RU2006134631A - Иммуногенные композиции против chlamidia pneumoniae - Google Patents
Иммуногенные композиции против chlamidia pneumoniae Download PDFInfo
- Publication number
- RU2006134631A RU2006134631A RU2006134631/13A RU2006134631A RU2006134631A RU 2006134631 A RU2006134631 A RU 2006134631A RU 2006134631/13 A RU2006134631/13 A RU 2006134631/13A RU 2006134631 A RU2006134631 A RU 2006134631A RU 2006134631 A RU2006134631 A RU 2006134631A
- Authority
- RU
- Russia
- Prior art keywords
- seq
- amino acid
- acid sequence
- individual
- polypeptide
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title claims 10
- 239000000203 mixture Substances 0.000 title claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 31
- 229920001184 polypeptide Polymers 0.000 claims abstract 31
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 31
- 239000012634 fragment Substances 0.000 claims abstract 16
- 230000028993 immune response Effects 0.000 claims abstract 16
- 108010073429 Type V Secretion Systems Proteins 0.000 claims abstract 13
- 150000001413 amino acids Chemical class 0.000 claims abstract 9
- 238000004519 manufacturing process Methods 0.000 claims abstract 5
- 239000000427 antigen Substances 0.000 claims abstract 4
- 102000036639 antigens Human genes 0.000 claims abstract 4
- 108091007433 antigens Proteins 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 3
- 208000015181 infectious disease Diseases 0.000 claims abstract 3
- 230000009885 systemic effect Effects 0.000 claims abstract 3
- 238000011282 treatment Methods 0.000 claims abstract 3
- 210000004027 cell Anatomy 0.000 claims abstract 2
- 210000000805 cytoplasm Anatomy 0.000 claims abstract 2
- 230000006698 induction Effects 0.000 claims abstract 2
- 230000028327 secretion Effects 0.000 claims abstract 2
- 210000002966 serum Anatomy 0.000 claims abstract 2
- 241001647372 Chlamydia pneumoniae Species 0.000 claims 14
- 238000000034 method Methods 0.000 claims 6
- 230000001939 inductive effect Effects 0.000 claims 5
- 239000011230 binding agent Substances 0.000 claims 4
- 229960001438 immunostimulant agent Drugs 0.000 claims 4
- 239000003022 immunostimulating agent Substances 0.000 claims 4
- 230000003308 immunostimulating effect Effects 0.000 claims 4
- 239000012472 biological sample Substances 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 238000011321 prophylaxis Methods 0.000 claims 2
- 206010061041 Chlamydial infection Diseases 0.000 claims 1
- 208000035086 Chlamydophila Infections Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54983204P | 2004-03-02 | 2004-03-02 | |
| US60/549,832 | 2004-03-02 | ||
| US64311005P | 2005-01-12 | 2005-01-12 | |
| US60/643,110 | 2005-01-12 | ||
| US64455205P | 2005-01-19 | 2005-01-19 | |
| US60/644,552 | 2005-01-19 | ||
| PCT/US2005/006588 WO2005084306A2 (en) | 2004-03-02 | 2005-03-02 | Immunogenic compositions for chlamydia pneunomiae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006134631A true RU2006134631A (ru) | 2008-04-10 |
Family
ID=34923269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006134631/13A RU2006134631A (ru) | 2004-03-02 | 2005-03-02 | Иммуногенные композиции против chlamidia pneumoniae |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1729800A4 (https=) |
| JP (1) | JP2007526318A (https=) |
| BR (1) | BRPI0508365A (https=) |
| CA (1) | CA2557353A1 (https=) |
| RU (1) | RU2006134631A (https=) |
| WO (1) | WO2005084306A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ599345A (en) | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
| AU2006214064B2 (en) | 2005-02-18 | 2012-04-26 | J. Craig Venter Institute, Inc. | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| WO2008020330A2 (en) | 2006-08-16 | 2008-02-21 | Novartis Ag | Immunogens from uropathogenic escherichia coli |
| CN102105786B (zh) * | 2008-07-25 | 2014-10-29 | 赛乐思迪斯有限公司 | 诊断方法 |
| NZ591768A (en) | 2008-09-18 | 2012-11-30 | Novartis Ag | Vaccine adjuvant combinations |
| ITMI20090946A1 (it) | 2009-05-28 | 2010-11-29 | Novartis Ag | Espressione di proteine ricombinanti |
| CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| KR20130121699A (ko) | 2010-05-28 | 2013-11-06 | 테트리스 온라인, 인코포레이티드 | 상호작용 혼성 비동기 컴퓨터 게임 기반구조 |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| US9618508B2 (en) | 2010-12-14 | 2017-04-11 | Glaxosmithkline Biologicals Sa | Flow cytometry analysis of materials adsorbed to metal salts |
| WO2012117377A1 (en) | 2011-03-02 | 2012-09-07 | Novartis Ag | Combination vaccines with lower doses of antigen and/or adjuvant |
| MX346678B (es) | 2012-03-07 | 2017-03-29 | Novartis Ag | Sales de arginina utiles inmunologicamente. |
| JP2015510872A (ja) | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 |
| MX372965B (es) | 2012-03-08 | 2020-04-01 | Glaxosmithkline Biologicals Sa | Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo. |
| JP6990522B2 (ja) | 2017-04-11 | 2022-02-03 | シスメックス株式会社 | 免疫細胞の免疫刺激応答性を測定する方法、免疫細胞における免疫シナプスの形成能を判定する方法及び細胞分析装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822071B1 (en) * | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
| WO2002002606A2 (en) * | 2000-07-03 | 2002-01-10 | Chiron S.P.A. | Immunisation against chlamydia pneumoniae |
-
2005
- 2005-03-02 CA CA002557353A patent/CA2557353A1/en not_active Abandoned
- 2005-03-02 BR BRPI0508365-6A patent/BRPI0508365A/pt not_active IP Right Cessation
- 2005-03-02 JP JP2007501899A patent/JP2007526318A/ja not_active Withdrawn
- 2005-03-02 RU RU2006134631/13A patent/RU2006134631A/ru not_active Application Discontinuation
- 2005-03-02 WO PCT/US2005/006588 patent/WO2005084306A2/en not_active Ceased
- 2005-03-02 EP EP05724183A patent/EP1729800A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1729800A2 (en) | 2006-12-13 |
| CA2557353A1 (en) | 2005-09-15 |
| WO2005084306A3 (en) | 2006-05-26 |
| JP2007526318A (ja) | 2007-09-13 |
| EP1729800A4 (en) | 2008-06-11 |
| BRPI0508365A (pt) | 2007-07-24 |
| WO2005084306A2 (en) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2006134631A (ru) | Иммуногенные композиции против chlamidia pneumoniae | |
| RU2006120003A (ru) | Соединения и способы для лечения и диагностики хламидийной инфекции | |
| AR003124A1 (es) | Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal, | |
| RU97100934A (ru) | Нуклеотидные последовательности пестивирусных штаммов, полипептиды, закодированные этими последовательностями, и их использование для диагностики и профилактики пестивирусных инфекций | |
| TWI541354B (zh) | 牙周病原菌血漿或血清抗體價檢查套組 | |
| US20200188510A1 (en) | Allergy antigen and epitope thereof | |
| PL351277A1 (en) | Nucleic acid sequence, dna fragments, recombined dna molecules, live recombined carriers, host cells, proteins and their application, vaccines against lawsonia intracellularis and methods of obtaining them as well as relevant diagnostic tests | |
| JP2026062649A (ja) | アレルギーの抗原およびそのエピトープ | |
| JP2007526318A5 (https=) | ||
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| BR0210143A (pt) | Fragmento de anticorpo recombinante, molécula de ácido nucleico, sequência de nucleotìdeo, processo para identificar fragmentos de anticorpo recombinante, uso do mesmo, preparação de agonistas contra a atividade biológica do ibdv, método para identificar um fragmento de anticorpo de ibdv recombinante, método para detectar a presença de anticorpo de ibdv em uma amostra, uso do mesmo, vetor, célula hospedeira recombinante, método para preparar um polipeptìdeo de anticorpo relacionado com o ibdv, conjunto para o diagnóstico de cepa do ibdv, composição terapêutica, método para tratar uma doença de ibdv, uso dos fragmentos de anticorpo recombinante | |
| EP3502128A2 (en) | Epitope | |
| EP2528939B1 (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| EP2149051B1 (de) | Verfahren und immunabsorbentien zur spezifischen detektion und absorption zöliakie- und dermatitis herpetiformis assoziierter antikörper | |
| US20200264193A1 (en) | Diagnostic markers for bovine tuberculosis and uses thereof | |
| WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
| DE602004024423D1 (de) | Impfstoff mit lawsonia intracellularis-untereinheit | |
| MXPA03009778A (es) | Pepetido de union de anticuerpos de la enfermedad de crohn y metodo de examinar la enfermedad de crohn. | |
| EP2199303B1 (de) | Polypeptide und Verfahren zur spezifischen Detektion von Antikörpern bei Patienten mit einer Borrelieninfektion | |
| RU2000131225A (ru) | Белки moraxella catarrhalis | |
| DK1541676T3 (da) | Mod prothrombin-fragment F1 2 rettede abtistoffer, deres fremstilling og anvendelse | |
| BR9506512A (pt) | Peptídeo ou conjugado de peptídeo de sequência de aminoácidos composiçao de vacina dna ou rna recombinante plasmídeo plasmídeo pgex célula anti-soro ou anticorpos processos para testar a presença ou quantidade de anticorpos para virus de arterite equina presente em uma amostra e para testar a presença de virus de arterite equina em uma amostra e kit de teste | |
| US20130251738A1 (en) | Vaccines | |
| US20210231678A1 (en) | Allergy antigen and epitope thereof | |
| JP2023109975A (ja) | 動物用製品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20091001 |